Market revenue in 2023 | USD 2,857.3 million |
Market revenue in 2030 | USD 4,816.8 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Japan formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The market for drug formulation development is growing in Japan because of the country's increasing aging population and the rise in the prevalence of chronic diseases like cancer. The new Pharmaceutical Affairs Law encourages research on cancer and tissue diagnostics, which is anticipated to drive market expansion.
Government programs are advancing R&D infrastructure and global strategy, such as the formation of the Japan Agency for Medical Research and Development (AMED) in 2015. The studies in drug formulation have been accelerated through a partnership between Janssen Pharmaceuticals and a Japanese business, PeptiDream, to optimize successful peptides into small molecule products or therapeutic peptides.
In general, it is anticipated that factors like Japan's aging population, updated legislation, government initiatives, and industry partnerships will promote the expansion of the formulation development outsourcing market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Japan formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account